Fund moves

GE HealthCare (GEHC): Letko, Brosseau & Associates Inc opened a new position $56.2M

Letko, Brosseau & Associates Inc opened a new position in GE HealthCare, per its Q2 2026 13F.

879K
Shares reported
0.83%
Disclosed portfolio weight
$56.2M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 13, 2026

What stands out in this filing

  • A new position in Q2 2026: 878,575 shares, none in the manager's Q1 2026 filing.
  • Reported at $56.2M, 0.83% of the portfolio value in this 13F filing.
  • 10 other tracked managers reported the same kind of change for Q2 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of GEHC — reported range $1,001 - $15,000
  2. Jul 21, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.”
  3. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  4. Jul 31, 2026FDARecall: Centricity Enterprise Archive V2, V3, and V4, software product for receiving, archiving, and sending electronic medical data, All Versions
  5. Jul 31, 2026FDARecall: Core Services Hub V8, a set of backend services including Cross Enterprise (XE) and Workflow Core (WFC) services that enables enterprise imaging workflows, All…
  6. Jul 31, 2026FDARecall: Workflow Core Services V8, intended to provide set of services for storage and retrieval of patient data, exams and performs system Administration, common conf…
  7. Aug 7, 2026FDAFDA device clearance: Venue Go
  8. Aug 7, 20265% stakeDodge & Cox reported a passive stake (13G) of 8.3%
  9. Aug 7, 20265% stakeDodge & Cox reported a passive stake (13G) of 10.5%
  10. Aug 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.”
  11. Aug 13, 2026FDAFDA device clearance: AIR Recon DL

What came next

  1. Aug 28, 2026FDAFDA device clearance: Carescape Canvas 1000; Carescape Canvas Smart Display
  2. Aug 28, 2026FDARecall: Senographe Pristina 3D
  3. Aug 28, 2026FDARecall: Senographe Pristina
  4. Aug 28, 2026FDARecall: Senographe Pristina
  5. Sep 1, 2026FDAFDA device clearance: Carescape ONE; Carescape Dock F0; TruSignal ECG MM; TruSignal PRES MM; TruSignal TEMP MM; TruSignal SpO2 MM 1.8M; TruSignal SpO2 MM 3.0M
  6. Sep 2, 2026FDAFDA device clearance: Vivid Explorer/Vivid Advanced/Vivid Focus
  7. Sep 16, 2026FDAFDA device clearance: EchoPAC Software Only / EchoPAC Plug-in (v211)
  8. Sep 22, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 22, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027.”
  9. Oct 2, 2026FDAFDA device clearance: Lung Guidance
  10. Oct 2, 2026FDAFDA device clearance: Voluson Expert 18; Voluson Expert 20; Voluson Expert 22
  11. Oct 22, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On October 22, 2026, Jeannette Bankes notified GE HealthCare that she will resign as President and CEO, Patient Care Solutions. Ms. Bankes' last day at GE HealthCare will be November 15, 2026.”
  12. Nov 3, 2026FDAFDA device clearance: 12SL Precision
  13. Nov 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 4, 2026, Taha Kass-Hout notified GE HealthCare Technologies Inc. (“GE HealthCare”) that he will resign as Chief Science and Technology Officer. Mr. Kass-Hout’s last day at GE HealthCare will be December 31, 2026.”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for GE HealthCare

For GE HealthCare, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GEHC page.

How this filing works

Explore the data

Common questions

What does this filing report about GE HealthCare (GEHC) stock?

Letko, Brosseau & Associates Inc opened a new position in GE HealthCare, per its Q2 2026 13F. 879K shares reported, 0.83% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 13, 2026.

What stands out in this filing?

A new position in Q2 2026: 878,575 shares, none in the manager's Q1 2026 filing. Reported at $56.2M, 0.83% of the portfolio value in this 13F filing. 10 other tracked managers reported the same kind of change for Q2 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about GE HealthCare recently?

For GE HealthCare, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GEHC page.

Does this mean GEHC stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at GE HealthCare

Everything OQRO holds on this company is on its GEHC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data